Literature DB >> 17962588

Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS).

Minesh Khatri1, Clinton B Wright, Thomas L Nickolas, Mitsuhiro Yoshita, Myunghee C Paik, Grace Kranwinkel, Ralph L Sacco, Charles DeCarli.   

Abstract

BACKGROUND AND
PURPOSE: White matter hyperintensities have been associated with increased risk of stroke, cognitive decline, and dementia. Chronic kidney disease is a risk factor for vascular disease and has been associated with inflammation and endothelial dysfunction, which have been implicated in the pathogenesis of white matter hyperintensities. Few studies have explored the relationship between chronic kidney disease and white matter hyperintensities.
METHODS: The Northern Manhattan Study is a prospective, community-based cohort of which a subset of stroke-free participants underwent MRIs. MRIs were analyzed quantitatively for white matter hyperintensities volume, which was log-transformed to yield a normal distribution (log-white matter hyperintensity volume). Kidney function was modeled using serum creatinine, the Cockcroft-Gault formula for creatinine clearance, and the Modification of Diet in Renal Disease formula for estimated glomerular filtration rate. Creatinine clearance and estimated glomerular filtration rate were trichotomized to 15 to 60 mL/min, 60 to 90 mL/min, and >90 mL/min (reference). Linear regression was used to measure the association between kidney function and log-white matter hyperintensity volume adjusting for age, gender, race-ethnicity, education, cardiac disease, diabetes, homocysteine, and hypertension.
RESULTS: Baseline data were available on 615 subjects (mean age 70 years, 60% women, 18% whites, 21% blacks, 62% Hispanics). In multivariate analysis, creatinine clearance 15 to 60 mL/min was associated with increased log-white matter hyperintensity volume (beta 0.322; 95% CI, 0.095 to 0.550) as was estimated glomerular filtration rate 15 to 60 mL/min (beta 0.322; 95% CI, 0.080 to 0.564). Serum creatinine, per 1-mg/dL increase, was also positively associated with log-white matter hyperintensity volume (beta 1.479; 95% CI, 1.067 to 2.050).
CONCLUSIONS: The association between moderate-severe chronic kidney disease and white matter hyperintensity volume highlights the growing importance of kidney disease as a possible determinant of cerebrovascular disease and/or as a marker of microangiopathy.

Entities:  

Mesh:

Year:  2007        PMID: 17962588      PMCID: PMC2948438          DOI: 10.1161/STROKEAHA.107.493593

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  49 in total

1.  Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine.

Authors:  V P Valkonen; H Päivä; J T Salonen; T A Lakka; T Lehtimäki; J Laakso; R Laaksonen
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.

Authors:  Alberto Martinez-Vea; Esther Salvadó; Alfredo Bardají; Cristina Gutierrez; Ana Ramos; Carmen García; Teresa Compte; Carmen Peralta; Montse Broch; Rosa Pastor; Pere Angelet; Luis Marcas; Amadeo Saurí; Jesús Angel Oliver
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

4.  Kidney function as a predictor of noncardiovascular mortality.

Authors:  Linda F Fried; Ronit Katz; Mark J Sarnak; Michael G Shlipak; Paulo H M Chaves; Nancy Swords Jenny; Catherine Stehman-Breen; Dan Gillen; Anthony J Bleyer; Calvin Hirsch; David Siscovick; Anne B Newman
Journal:  J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 10.121

5.  Rates of dementia in three ethnoracial groups.

Authors:  B J Gurland; D E Wilder; R Lantigua; Y Stern; J Chen; E H Killeffer; R Mayeux
Journal:  Int J Geriatr Psychiatry       Date:  1999-06       Impact factor: 3.485

6.  Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.

Authors:  Prabath W B Nanayakkara; Tom Teerlink; Coen D A Stehouwer; Daud Allajar; Annemieke Spijkerman; Casper Schalkwijk; Piet M ter Wee; Coen van Guldener
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

7.  Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.

Authors:  Clinton B Wright; Myunghee C Paik; Truman R Brown; Sally P Stabler; Robert H Allen; Ralph L Sacco; Charles DeCarli
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

8.  Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.

Authors:  Sarah E Vermeer; Ewoud J van Dijk; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Robert Clarke; Monique M B Breteler
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

9.  Associations of the angiotensin II type 1 receptor A1166C and the endothelial NO synthase G894T gene polymorphisms with silent subcortical white matter lesions in essential hypertension.

Authors:  Léon H G Henskens; Abraham A Kroon; Martin P J van Boxtel; Paul A M Hofman; Peter W de Leeuw
Journal:  Stroke       Date:  2005-08-18       Impact factor: 7.914

Review 10.  The endothelin system and its antagonism in chronic kidney disease.

Authors:  Neeraj Dhaun; Jane Goddard; David J Webb
Journal:  J Am Soc Nephrol       Date:  2006-03-15       Impact factor: 10.121

View more
  84 in total

1.  Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.

Authors:  Mariana Murea; Fang-Chi Hsu; Amanda J Cox; Christina E Hugenschmidt; Jianzhao Xu; Jeremy N Adams; Laura M Raffield; Christopher T Whitlow; Joseph A Maldjian; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2015-02-26       Impact factor: 5.992

Review 2.  Symptom Management of the Patient with CKD: The Role of Dialysis.

Authors:  Valerie Jorge Cabrera; Joni Hansson; Alan S Kliger; Fredric O Finkelstein
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-01       Impact factor: 8.237

Review 3.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

4.  Renal dysfunction is associated with deep cerebral microbleeds but not white matter hyperintensities in patients with acute intracerebral hemorrhage.

Authors:  Mona Laible; Solveig Horstmann; Markus Möhlenbruch; Christian Wegele; Timolaos Rizos; Svenja Schüler; Markus Zorn; Roland Veltkamp
Journal:  J Neurol       Date:  2015-07-15       Impact factor: 4.849

Review 5.  Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care.

Authors:  Dirk M Hermann; Andreas Kribben; Heike Bruck
Journal:  J Neural Transm (Vienna)       Date:  2014-01-23       Impact factor: 3.575

Review 6.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.

Authors:  Daniel E Weiner; Keith Bartolomei; Tammy Scott; Lori Lyn Price; John L Griffith; Irwin Rosenberg; Andrew S Levey; Marshal F Folstein; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2008-12-12       Impact factor: 8.860

8.  MRI Features and Site-specific Factors of Ischemic Changes in White Matter: A Retrospective Study.

Authors:  You-Ping Zhang; Na Liu; Kai-Yan Liu; Chao Pan; Xuan Cai; Shi-Qi Yang; Zhou-Ping Tang; Sha-Bei Xu
Journal:  Curr Med Sci       Date:  2018-04-30

9.  Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.

Authors:  Clinton B Wright; Nirav H Shah; Armando J Mendez; Janet T DeRosa; Mitsuhiro Yoshita; Mitchell S V Elkind; Ralph L Sacco; Charles DeCarli; Tatjana Rundek; Shonni Silverberg; Chuanhui Dong; Myles Wolf
Journal:  Stroke       Date:  2016-03-08       Impact factor: 7.914

10.  Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.

Authors:  Jasmine Nettiksimmons; Laurel Beckett; Christopher Schwarz; Owen Carmichael; Evan Fletcher; Charles Decarli
Journal:  Psychol Aging       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.